Barclays analyst Benjamin Budish maintains CME Gr (NASDAQ:CME) with a Equal-Weight and raises the price target from $225 to $226.
Barclays Maintains Equal-Weight on CME Gr, Raises Price Target to $226
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.